Business Segments


With a decade of experience in Market Research, Product Development and Licensing, REVA is leading in the following segments:

Oncology

Cancer is a global threat with more than 18 million new cases expected annually. It is estimated that 9.6 million people died from various forms of the disease in 2018 as per the UN’s International Agency for Research on Cancer (IARC). According to IARC’s report one in five men and one in six women worldwide, develop cancer during their lifetime, and one in eight men and one in 11 women die from it. Efficient prevention and early detection policies will have to be implemented to complement treatments in order to control this devastating disease across the world.

REVA, as its social responsibility, is working towards addressing the menace. Our focus will be towards offering accessible, affordable and quality oncology medicine for Breast and Cervix cancer.

Women's Health

Women across the world face a multitude of health problems. Poor maternal health often affects a child's health in adverse ways, which ultimately affect negatively creation of quality human capital. Nutrition also plays a major role in individual's overall health; psycho, logical and physical health status is often dramatically impacted by malnutrition. Our range includes:

  • Osteoporosis
  • Anaemia
  • Gynaecology


  • Lifestyle Drugs

    In this modern era, diseases caused by errant lifestyle of human beings are most common. The Lifestyle Drugs have become a necessity and we are investing heavily to offer broad spectrum for treatment of:

  • Diabetics
  • Pain Management
  • Cardio
  • CNS


  • Tropical Disease

    Tropical diseases encompass all diseases that occur principally, in the tropics. REVA as an organization, in line with its motto “Caring for Healthier Lives” is working closely with Governments / Non-profit Industry to offer accessible, affordable and quality medicines.

  • Malaria
  • HIV
  • TB
  • Hepatitis